Sources: Core Scientific's hedge fund shareholders may reject CoreWeave's all-stock merger bid, seeking better terms, as CRWV has fallen 30%+ post-announcement — Some investment funds may vote against deal unless protections are added to limit the potential downside — Unlock the Editor's Digest for free
Posted from: this blog via Microsoft Power Automate.